#156437

MDA-MB-231 CAGA12-Luc/TK Renilla cell line

Cat. #156437

MDA-MB-231 CAGA12-Luc/TK Renilla cell line

Cat. #: 156437

Sub-type: Continuous

Unit size: 1x10^6 cells / vial

Availability: 8-10 weeks

Organism: Human

Tissue: Breast

Disease: Cancer

Model: Reporter

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Caroline Hill

Institute: The Francis Crick Institute

Tool Details
Target Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: MDA-MB-231 CAGA12-Luc/TK Renilla cell line
  • Cancer type filter: Breast cancer
  • Cancers detailed: Breast cancer
  • Research fields: Cancer;Cell signaling and signal transduction;Developmental biology
  • Tool sub type: Continuous
  • Parental cell: MDA-MB-231 cell line
  • Organism: Human
  • Tissue: Breast
  • Disease: Cancer
  • Model: Reporter
  • Conditional description: In the presence of activin and TGF-beta signalling luciferase is expressed.
  • Description: The human breast cancer cell line MDA-MB-31 modified for use as a reporter cell line for Activin and TGF-beta signalling. The cell line stably expresses CAGA12-Luc, a Smad3/Smad4-dependent reporter containing 12 copies of the CAGAC sites (AGAC motif underlined) from the PAI-1 promoter. This is a Smad3/Smad4-dependent reporter, although it also binds complexes of Smad2 exon 3 with Smad4. The cell line also contains a Renilla reporter driven by the thymidine kinase (TK) promoter to act as an internal control.
  • Production details: Made by transfecting the breast cancer cell line MDA-MB-231 with CAGA12-Luc with pRetroSuper for puromycin resistance and then TK Renilla with pCMV-Bsd for blasticidin resistance.Clonal
  • Biosafety level: 1
  • Recommended controls: MDA-MB-231 parental line

Target Details

  • Target: Activin and transforming growth factor Î?‹Â› (TGF-Î?‹Â›)Â?‚ signalling

Handling

  • Format: Frozen
  • Growth medium: Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum (FCS)+ 50 ?g/ml blasticidin
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice
  • Storage conditions: Liquid Nitrogen
  • Mycoplasma free: Yes

Related Tools

  • Related tools: HEK293T CAGA12-Luc/TK Renilla cell line

References

  • Grnroos et al. 2012. Mol Cell Biol. 32(14):2904-16. PMID: 22615489.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.